MesotheliomaDR logo

24/7 Patient Assistance: 760-405-8205

Shuko Harada, MD

Pathologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Asbestosis Clubbed Fingers Diffuse Pleural Thickening Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Effusions Pleural Mesothelioma Pleural Plaques Pleuritis Rounded Atelectasis Testicular Mesothelioma

Hospitals & Clinics

UAB Hospital

specialties & services

Cancer Antigen 125, CA Fibulin-3 Human MPF ELISA Kit Mesomark Osteopontin SOMAmer Panel

  • Bio & Insurance Information

    Dr. Shuko Harada did her medical school at the University of Tokyo. She did her residency program at the Hahnemann University Hospital, Drexel University. She also did a fellowship at the Johns Hopkins University and is board certified in pathology. Dr. Harada is affiliated with the University of Alabama Hospital and during her medical career, she contributed to three research publications along with other doctors.

    Insurance Accepted

    AetnaCignaHumanaUnited Healthcare

  • Education & Training

    dept_icon

    Graduate School of Medicine and Faculty of Medicine, The University of Tokyo

    Medical School

    dept_icon

    Drexel University - Hahnemann University Hospital

    Residency

    dept_icon

    Johns Hopkins University

    Fellowship

  • Board Certifications

    American Board of Pathology

  • Hospital & Practice

    UAB Hospital

    Languages: English/Spanish

    (205) 934-3411

    1802 6th Ave S

    Birmingham, Alabama 35233

    Read More
  • Publications & Memberships

    Dr. Shuko Harada has contributed to 3 publications.

    The Utility of Phosphohistone H3 in Breast Cancer Grading.

    Cui, X.,Harada, S.,Shen, D.,Siegal, G. P.,Wei, S.; Appl. Immunohistochem. Mol. Morphol.. 2015 Jan 23.

    See more >>

    Molecular Pathology: LC18-1 MOLECULAR TESTING FOR TARGETED THERAPY - SEQUENCING BASED ASSAY.

    Harada, S.; Pathology. 2014 Sep 05.

    See more >>

    Molecular Pathology: SC18-1 INTERESTING CASE - ACTIONABLE MUTATION IN A CASE WITH A RECURRENT PLEOMORPHIC XANTHOASTROCYTOMA WITH ANAPLASTIC FEATURES.

    Harada, S.,Fallon, K. B.,Reddy, A.,Nabors, L. B.; Pathology. 2014 Sep 05.

    See more >>